Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Shin SH, Hung CL, Uno H, Hassanein AH, Verma A, Bourgoun M, Køber L, Ghali JK, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Shin SH, et al. Among authors: verma a. Circulation. 2010 Mar 9;121(9):1096-103. doi: 10.1161/CIRCULATIONAHA.109.863795. Epub 2010 Feb 22. Circulation. 2010. PMID: 20176989
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD. Meris A, et al. Among authors: verma a. Eur Heart J. 2009 Jan;30(1):56-65. doi: 10.1093/eurheartj/ehn499. Epub 2008 Nov 11. Eur Heart J. 2009. PMID: 19001474
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators. Solomon SD, et al. Among authors: verma a. Circulation. 2009 Feb 3;119(4):530-7. doi: 10.1161/CIRCULATIONAHA.108.826214. Epub 2009 Jan 19. Circulation. 2009. PMID: 19153265 Clinical Trial.
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Verma A, et al. JACC Cardiovasc Imaging. 2008 Sep;1(5):582-91. doi: 10.1016/j.jcmg.2008.05.012. JACC Cardiovasc Imaging. 2008. PMID: 19356485 Free article. Clinical Trial.
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
Shah AM, Hung CL, Shin SH, Skali H, Verma A, Ghali JK, Køber L, Velazquez EJ, Rouleau JL, McMurray JJ, Pfeffer MA, Solomon SD. Shah AM, et al. Among authors: verma a. Am Heart J. 2011 Oct;162(4):685-91. doi: 10.1016/j.ahj.2011.07.015. Epub 2011 Sep 14. Am Heart J. 2011. PMID: 21982661
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.
Meris A, Amigoni M, Verma A, Thune JJ, Køber L, Velazquez E, McMurray JJ, Pfeffer MA, Califf R, Levine RA, Solomon SD; Valsartan in Acute Myocardial Infarction (VALIANT) Investigators. Meris A, et al. Among authors: verma a. J Am Soc Echocardiogr. 2012 May;25(5):535-42. doi: 10.1016/j.echo.2012.01.006. Epub 2012 Feb 4. J Am Soc Echocardiogr. 2012. PMID: 22305962 Free PMC article. Clinical Trial.
5,582 results